“…The median level of CD38 among ZAP-70-negative cases was 5.3%, when compared with 27.2% among ZAP-70-positive cases (P < 0.0001) (36). This is consistent with other investigators who have used CD38 and ZAP-70 expression to predict the time to first treatment (8,9,11,18,33,39 A and B).…”